National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

4'-iodo-4'-deoxydoxorubicin
An iodinated doxorubicin analogue with antiamyloid activity. 4'-Iodo-4'-deoxydoxorubicin (IDOX) binds with high affinity to five types of natural amyloid fibrils including immunoglobulin light chains, amyloid A, transthyretin (methionine-30 variant), ß-protein (Alzheimer), and ß2-microglobulin. This agent may inhibit fibril growth, increasing the solubility of amyloid tissue deposits and facilitating their clearance. IDOX has also been shown to insulin amyloid fibrillogenesis in vitro. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:iododoxorubicin
Abbreviation:IDOX



Previous:18F-fluoromisonidazole, 2-methoxyestradiol, 3'-deoxy-3'-[18F]fluorothymidine, 3,4-methylenedioxymethamphetamine, 3-deazauridine
Next:4-hydroxytamoxifen, 4-nitroestrone 3-methyl ether, 5,10-methylenetetrahydrofolate, 5-[18F]fluorouracil, 5-hydroxytryptophan

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov